Skip to Main Content

Paper Details

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
Clin Cancer Res
6
2015
Cyclophosphamide, GVHD, Graft-versus-Tumor, PC, Patients, Pentostatin, RCC, Sirolimus, T, T cells, T-Rapa, T-cell-replete peripheral blood stem cell allografts, acute GVHD, allogeneic T cells, antitumor, cancer, cyclophosphamide, donor lymphocyte, graft, metastatic renal cell carcinoma, neutropenia, patients, pentostatin, sirolimus, sirolimus-resistant allogeneic T cells
Author NameAffiliation
David C HalversonCenter for Cancer Research
David C HalversonCenter for Cancer Research
Seth M Steinberg
Seth M Steinberg
Frances T HakimCenter for Cancer Research
Frances T HakimCenter for Cancer Research
Steven Z PavleticCenter for Cancer Research
Steven Z PavleticCenter for Cancer Research
David F StroncekClinical Center
David F StroncekClinical Center
Carl H JuneUniversity of Pennsylvania, Abramson Family Cancer Research Center
Ronald E GressCenter for Cancer Research
Ronald E GressCenter for Cancer Research
Daniel H FowlerCenter for Cancer Research
Daniel H FowlerCenter for Cancer Research
  • 1 - 15

Datasets

Release 1.2